Optomed 

€1.3880
6
+€0.04+3.12%星期一 07:23

統計

當日最高
1.388
當日最低
1.388
52週高點
4.11
52週低點
1.332
成交量
-
平均成交量
-
市值
29.75M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

11月6日預期
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
下一步
-0.09
-0.07
-0.05
-0.03
預期EPS
-0.02530453029
實際EPS
不適用

財務

0.68%利潤率
有盈利
2021
2022
2023
2024
2025
2026
2.22M營收
15,000淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 36U0.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Optomed Oyj, established in 2004 and headquartered in Oulu, Finland, is a medical technology company specializing in the development, production, and sale of portable devices for retinal examination and advanced screening software. The company operates globally, with a presence in Finland and China, structured into dedicated Devices and Software segments. Its Device division focuses on fundus cameras, serving a broad spectrum of medical specialists, including ophthalmologists, pediatricians, endocrinologists, neurologists, and general practitioners. These camera products are marketed under Optomed's own brand names such as Optomed Smartscope Pro, Aurora, Polaris, and Halo, and are also provided as OEM products under labels including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal. The Software segment offers a comprehensive suite of solutions. For eye health, this includes Avenue Eye Screen for managing the workflow of eye disease screening and monitoring (like diabetic retinopathy), Avenue Archive for healthcare data storage and transmission, Avenue Telemedicine for remote image analysis, Avenue AI for automated diabetic retinopathy screening, and Avenue Sync for seamless integration of fundus cameras with hospital systems. Beyond eye care, Optomed provides Avenue Cancer Screen for managing breast, cervical, and colorectal cancer screenings; Optomed RIS for optimizing diagnostic processes in healthcare imaging units; Sectra PACS, a scalable system for high-volume healthcare providers; Optomed Service Portal for supporting imaging service operations; Facad for visible light imaging and cephalometric tracing; and Sectra PACS Pathology, a digital solution for the distribution and diagnosis of scanned glass slides. Furthermore, Optomed extends professional IT consulting services to government bodies. The company's products and solutions are distributed through OEMs, authorized distributors, and its direct sales channels. Its primary clientele includes hospitals, specialized eye clinics, and both independent and chain optician stores.
顯示更多
執行長
Juho Himberg
員工
110
國家
芬蘭
ISIN
FI4000410881
WKN
000A2PWGR

上市

0 則留言

分享你的想法

常見問題

Optomed 今天的股價是多少?▼
36U0.F 目前價格為 €1.39 EUR,過去 24 小時上漲了 +3.12%。在圖表上更密切關注 Optomed 股價表現。
Optomed 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Frankfurt Exchange 交易所,Optomed 的股票以代號 36U0.F 進行交易。
Optomed 的股價在上漲嗎?▼
36U0.F 股票較上週上漲 +2.36%,本月下跌 -4.14%,過去一年 Optomed 下跌 -64.09%。
Optomed 的市值是多少?▼
今天 Optomed 的市值為 29.75M
Optomed 下一次財報日期是什麼時候?▼
Optomed 將於 2026年11月6日 公布下一次財報。
Optomed 上一季度的財報如何?▼
36U0.F 上一季度的財報為每股 -0.04 EUR,預估為 -0.05 EUR,帶來 +22.71% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Optomed 去年的營收是多少?▼
Optomed 去年的營收為 2.22MEUR。
Optomed 去年的淨利是多少?▼
36U0.F 去年的淨收益為 15,000EUR。
Optomed 有多少名員工?▼
截至 2026年11月3日,公司共有 110 名員工。
Optomed 位於哪個產業?▼
Optomed從事於Health & Wellness產業。
Optomed 何時完成拆股?▼
Optomed 最近沒有進行任何拆股。
Optomed 的總部在哪裡?▼
Optomed 的總部位於 芬蘭 的 Oulu。